The structure of secretin family GPCR peptide ligands: Implications for receptor pharmacology and drug development

Drug Discovery Today

Volumn 17, Issue 17-18, 2012, Pages 1006-1014

  Watkins, Harriet A ^a   Au, Maggie ^a   Hay, Debbie L ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AC 253; ALBIGLUTIDE; DAVALINTIDE; EXENDIN 4; G PROTEIN COUPLED RECEPTOR; LIGAND; LIXISENATIDE; PHENYLALANINE DERIVATIVE; PRAMLINTIDE; SECRETIN; UNCLASSIFIED DRUG;

ACTIN CAPPING; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DRUG ACTIVITY; HUMAN; INFLAMMATION; MICELLE; MIGRAINE; NONHUMAN; OSTEOPOROSIS; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; DRUG DESIGN; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; SECRETIN;

EID: 84865525059     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.05.005     Document Type: Review

References (74)

1. J.K. Archbold Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development Trends Pharmacol. Sci. 32 2011 591 600
2. R. Fredriksson The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints Mol. Pharmacol. 63 2003 1256 1272 (Pubitemid 36627220)
3. S.G. Furness Consequences of splice variation on Secretin family G protein-coupled receptor function Br. J. Pharmacol. 166 2011 98 109
4. L.M. McLatchie RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor Nature 393 1998 333 339 (Pubitemid 28269699)
5. C. Parthier Passing the baton in class B GPCRs: peptide hormone activation via helix induction? Trends Biochem. Sci. 34 2009 303 310
6. S.G. Howitt The role of the 8-18 helix of CGRP8-37 in mediating high affinity binding to CGRP receptors; coulombic and steric interactions Br. J. Pharmacol. 138 2003 325 332 (Pubitemid 36188594)
7. H. Inooka Conformation of a peptide ligand bound to its G-protein coupled receptor Nat. Struct. Biol. 8 2001 161 165 (Pubitemid 32116070)
8. C. Parthier Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor Proc. Natl. Acad. Sci. U. S. A. 104 2007 13942 13947 (Pubitemid 350003317)
9. D.V. Paone Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl] -4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide (MK-0974) J. Med. Chem. 50 2007 5564 5567 (Pubitemid 350106011)
10. A. Recober, and A.F. Russo Olcegepant, a non-peptide CGRP1 antagonist for migraine treatment IDrugs 10 2007 566 574 (Pubitemid 47186510)
11. K. Bellmann-Sickert, and A.G. Beck-Sickinger Peptide drugs to target G protein-coupled receptors Trends Pharmacol. Sci. 31 2010 434 441
12. M.C. Chapter Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies Pharmacol. Ther. 125 2010 39 54
13. J.M. Fisher, and R.H. Scheller Prohormone processing and the secretory pathway J. Biol. Chem. 263 1988 16515 16518 (Pubitemid 18268825)
14. D.F. Mierke Structural characterization of the parathyroid hormone receptor domains determinant for ligand binding Biochem. Soc. Trans. 35 2007 721 723 (Pubitemid 47310353)
15. J.T. Potts Jr. Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone Proc. Natl. Acad. Sci. U. S. A. 68 1971 63 67
16. C. Koole Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation J. Biol. Chem. 287 2012 3642 3658
17. C. Orskov Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans Diabetes 43 1994 535 539 (Pubitemid 24096293)
18. S. Eguchi Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells FEBS Lett. 340 1994 226 230 (Pubitemid 24080955)
19. Y. Hong The pharmacology of adrenomedullin 2/intermedin Br. J. Pharmacol. 166 2011 110 120
20. R.M. Robinson Lipid-induced conformational changes in glucagon, secretin, and vasoactive intestinal peptide Biopolymers 21 1982 1217 1228 (Pubitemid 12033688)
21. A.M. Gronenborn A 1H-NMR study of the solution conformation of secretin. Resonance assignment and secondary structure FEBS Lett. 215 1987 88 94 (Pubitemid 17099144)
22. S.D. Robinson Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3 J. Pharmacol. Exp. Ther. 331 2009 513 521
23. J.P. Meyer Solution structure of salmon calcitonin Biopolymers 31 1991 233 241
24. K. Ogawa Conformational analysis of human calcitonin in solution J. Pept. Sci. 12 2006 51 57 (Pubitemid 43033698)
25. P. Amodeo Conformational flexibility in calcitonin: the dynamic properties of human and salmon calcitonin in solution J. Biomol. NMR 13 1999 161 174 (Pubitemid 29089226)
26. A. Motta Sequential 1H NMR assignment and secondary structure determination of salmon calcitonin in solution Biochemistry 28 1989 7996 8002 (Pubitemid 19252879)
27. A. Motta A 1H NMR study of human calcitonin in solution Biochemistry 30 1991 2364 2371
28. C.R. Grace Common and divergent structural features of a series of corticotropin releasing factor-related peptides J. Am. Chem. Soc. 129 2007 16102 16114
29. M. Hofmann Conformation of secretin in dimethyl sulfoxide solution. NMR studies and restrained molecular dynamics Eur. J. Biochem. 186 1989 95 103 (Pubitemid 20015131)
30. M.P. Herrmann-Erlee Effects of bone in vitro of bovine parathyroid hormone and synthetic fragments representing residues 1-34, 2-34 and 3-34 Endocr. Res. Commun. 3 1976 21 35
31. J.A. Barden, and B.E. Kemp NMR solution structure of human parathyroid hormone(1-34) Biochemistry 32 1993 7126 7132 (Pubitemid 23223115)
32. J.W. Neidigh Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states Biochemistry 40 2001 13188 13200 (Pubitemid 33043533)
33. Z. Chen Solution structure of the osteogenic 1-31 fragment of the human parathyroid hormone Biochemistry 39 2000 12766 12777
34. Y. Hashimoto Effects of glycosylation on the structure and dynamics of eel calcitonin in micelles and lipid bilayers determined by nuclear magnetic resonance spectroscopy Biochemistry 38 1999 8377 8384
35. A. Motta Solution conformation of salmon calcitonin in sodium dodecyl sulfate micelles as determined by two-dimensional NMR and distance geometry calculations Biochemistry 30 1991 10444 10450
36. Y. Umetsu Structural difference of vasoactive intestinal peptide in two distinct membrane-mimicking environments Biochim. Biophys. Acta 1814 2011 724 730
37. S.M. Patil Dynamic alpha-helix structure of micelle-bound human amylin J. Biol. Chem. 284 2009 11982 11991
38. N. Komi Structural analysis of pituitary adenylate cyclase-activating polypeptides bound to phospholipid membranes by magic angle spinning solid-state NMR Biochim. Biophys. Acta 1768 2007 3001 3011 (Pubitemid 350236101)
39. R.P. Nanga Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy J. Am. Chem. Soc. 131 2009 8252 8261
40. R.P. Nanga Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment Biochim. Biophys. Acta 1808 2011 2337 2342
41. J.M. Neumann Class-B GPCR activation: is ligand helix-capping the key? Trends Biochem. Sci. 33 2008 314 319
42. N.M. Sherwood The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily Endocr. Rev. 21 2000 619 670 (Pubitemid 32113287)
43. T. Yaqub Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand Mol. Pharmacol. 77 2010 547 558
44. M. Dong Refinement of the pharmacophore of an agonist ligand of the secretin receptor using conformationally constrained cyclic hexapeptides Peptides 31 2010 1094 1098
45. A. Hareter The positive charge of the imidazole side chain of histidine7 is crucial for GLP-1 action Endocr. J. 44 1997 701 705 (Pubitemid 28011459)
46. P. Nicole Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide J. Biol. Chem. 275 2000 24003 24012 (Pubitemid 30624691)
47. J. Barwell Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs? Br. J. Pharmacol. 2011 10.1111/j.1476-5381.2011. 01525.x
48. R.M. Solano Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction J. Biol. Chem. 276 2001 1084 1088 (Pubitemid 32098012)
49. P. Perret Affinity labeling of cysteine-mutants evidences contact residues in modeled receptor binding sites J. Recept. Signal Transduct. Res. 22 2002 345 356 (Pubitemid 36169157)
50. D.D. Smith Modifications to the N-terminus but not the C-terminus of calcitonin gene-related peptide (8-37) produce antagonists with increased affinity J. Med. Chem. 46 2003 2427 2435 (Pubitemid 36637926)
51. R. Aurora, and G.D. Rose Helix capping Protein Sci. 7 1998 21 38 (Pubitemid 28133743)
52. A.A. Pioszak Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1 J. Biol. Chem. 283 2008 32900 32912
53. M. Lang Identification of the key residue of calcitonin gene related peptide (CGRP) 27-37 to obtain antagonists with picomolar affinity at the CGRP receptor J. Med. Chem. 49 2006 616 624 (Pubitemid 43157492)
54. R.K. Campbell Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus Clin. Ther. 33 2011 511 527
55. C. Mapelli Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity J. Med. Chem. 52 2009 7788 7799
56. T.S. Haque Identification of potent 11mer glucagon-like peptide-1 receptor agonist peptides with novel C-terminal amino acids: homohomophenylalanine analogs Peptides 31 2010 950 955
57. G. Ryan Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes Drug Des. Dev. Ther. 2 2009 203 214
58. C.M. Mack Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight Int. J. Obes. 34 2010 385 395
59. R. Huang NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG J. Mol. Biol. 416 2011 108 120
60. C. Devigny Biomimetic screening of class-B G protein-coupled receptors J. Am. Chem. Soc. 133 2011 8927 8933
61. Y. Yamada New class of corticotropin-releasing factor (CRF) antagonists: small peptides having high binding affinity for CRF receptor J. Med. Chem. 47 2004 1075 1078 (Pubitemid 38229109)
62. M. Buck Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins Q. Rev. Biophys. 31 1998 297 355 (Pubitemid 29213772)
63. I. Baskakov, and D.W. Bolen Forcing thermodynamically unfolded proteins to fold J. Biol. Chem. 273 1998 4831 4834 (Pubitemid 28108630)
64. A.L. Breeze Solution structure of human calcitonin gene-related peptide by 1H NMR and distance geometry with restrained molecular dynamics Biochemistry 30 1991 575 582
65. A.K. Malde Understanding interactions of gastric inhibitory polypeptide (GIP) with its G-protein coupled receptor through NMR and molecular modeling J. Pept. Sci. 13 2007 287 300 (Pubitemid 46730568)
66. K.C. Venneti Conformational, receptor interaction and alanine scan studies of glucose-dependent insulinotropic polypeptide Biochim. Biophys. Acta 1814 2011 882 888
67. J. Perez-Castells Structure of micelle-bound adrenomedullin, a first step towards the analysis of its interactions with receptors and small molecules Biopolymers 97 2012 45 53
68. C. Romier Solution structure of human corticotropin releasing factor by 1H NMR and distance geometry with restrained molecular dynamics Protein Eng. 6 1993 149 156 (Pubitemid 23100794)
69. V. Wray Solution structure comparison of the VIP/PACAP family of peptides by NMR spectroscopy Ann. N. Y. Acad. Sci. 865 1998 37 44 (Pubitemid 29047809)
70. Y.V. Tan Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modeling J. Biol. Chem. 281 2006 12792 12798
71. J.A. Barden, and R.M. Cuthbertson Stabilized NMR structure of human parathyroid hormone(1-34) Eur. J. Biochem. 215 1993 315 321 (Pubitemid 23224315)
72. K. Kanaori Comparative study of chicken and human parathyroid hormone-(1-34)-peptides in solution with SDS Eur. J. Biochem. 249 1997 878 885 (Pubitemid 27479063)
73. J.R. Cort Solution state structures of human pancreatic amylin and pramlintide Protein Eng. Des. Sel. 22 2009 497 513
74. L. Pauling, and R.B. Corey The structure of synthetic polypeptides Proc. Natl. Acad. Sci. U. S. A. 37 1951 241 250